45 results about "Basic fibroblast growth factor" patented technology

The invention relates to morin nanoparticles, pH responsive hydrogel and application of the morin nanoparticles and the pH responsive hydrogel. The morin-loaded nanoparticles provided by the invention can be rapidly degraded in an alkaline environment, have certain stability in an acidic environment, have the capability of releasing morin in response to pH, and can realize accurate regulation and control of morin release according to the change of environmental pH. According to the invention, hyaluronic acid is further subjected to methacrylation treatment, such that MeHA is obtained. The characteristic that MeHA is easier to degrade in an acid environment is utilized, and MeHA is used as hydrogel to load CFMNPs and can be effectively used for treating wounds caused by burns and frostbite. Furthermore, the pH responsive double-layer hydrogel based on pigment nanoparticles-basic fibroblast growth factors can realize sequential release of the effective components according to the change of the pH value of the burn or frostbite wound. The composition can effectively inhibit inflammation, resist oxidative stress, promote proliferation and migration of endothelial cells, promote neovascularization and finally accelerate wound healing.

The invention relates to an extraction and culture method of urine-derived stem cells, and belongs to the field of cell biology and regenerative medicine. The method comprises the following steps: coating a culture plate with a gelatin solution; collecting clean midstream urine of healthy people and adding antibiotics; centrifugally separating the cell precipitate; washing with a phosphate buffer solution; re-suspending the precipitate by using a urine stem cell complete culture medium for primary culture; and after the cells grow to a certain fusion degree, carrying out passage amplification. The urine stem cell complete medium comprises a basic medium, fetal calf serum, epidermal growth factors, platelet-derived growth factors and basic fibroblast growth factors. By adopting the method disclosed by the invention, the urine-derived stem cells can be efficiently and stably separated from urine, and the obtained cells have high multiplication capacity, good stemness maintaining capacity, multidirectional differentiation potential and immunoregulation function, and can provide an ideal seed cell source for treating diseases such as diabetic erectile dysfunction.

The invention relates to an external degradable microneedle patch as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The preparation method comprises the following steps: S1, preparing powdery CS-TA; s2, preparing a powdery Cu-TA nano enzyme; s3, adding the Cu-TA nano-enzyme and glucose oxidase GOD into water, stirring at 1-4 DEG C in an inert gas atmosphere, centrifuging, and re-suspending in water to obtain a GOD-coated Cu-TA compound enzyme solution; s4, adding CS-TA, hyaluronic acid, polyvinylpyrrolidone, L-arginine and a basic fibroblast growth factor into the GOD (at) Cu-TA compound enzyme solution, and preparing a microneedle mother solution; s5, preparing an aqueous solution containing CS-TA, hyaluronic acid and polyvinylpyrrolidone to obtain a substrate mother solution; and S6, filling a microneedle mold cavity of a mold with the microneedle mother solution to form enzyme series microneedles arranged in an array, then pouring a substrate mother solution to form a substrate, drying, and demolding to obtain the external degradable microneedle patch.

The present application relates to the technical field of biology, and particularly relates to a mesenchymal stem cell culture medium and a preparation method and application thereof.The mesenchymal stem cell culture medium comprises a basic culture medium, fetal bovine serum, basic fibroblast growth factor, polymyxin B and deionized water.The present application can simultaneously improve the proliferation activity of mesenchymal stem cells and the secretion performance of HGF by simultaneously adding the basic fibroblast growth factor and the polymyxin B in the basic culture medium; more stem cells can be in the active proliferation and division process by limiting the content of the basic fibroblast growth factor in the mesenchymal stem cell culture medium to 5-50 ng / mL; and the secretion performance of HGF can be improved while the cell proliferation activity is maintained by limiting the content of the polymyxin B in the mesenchymal stem cell culture medium to 50-100 mu g / mL.

The invention discloses a serum substitute compatible umbilical cord mesenchymal stem cell culture medium additive composition and application thereof. The serum substitute compatible umbilical cord mesenchymal stem cell culture medium additive composition is prepared from the following components in parts by mass: 15 to 25 parts of platelet-derived growth factor-BB; 15 to 25 parts of basic fibroblast growth factors; 8 to 12 parts of transforming growth factor-beta; and 8-12 parts of recombinant human insulin. The serum substitute compatible umbilical cord mesenchymal stem cell culture medium additive composition and the application thereof disclosed by the invention have the following beneficial effects: (1) the proliferation efficiency is remarkably improved; (2) the cell morphology and dryness can be well maintained; and (3) the compliance and the compatibility are good.

The invention provides a special culture medium for prostate cancer organoid and a culture method thereof, and belongs to the technical field of biological medicines. The special culture medium for the prostatic cancer organoid is composed of a basic culture medium and a culture additive, and the basic culture medium does not contain exogenously added Noggin recombinant protein and R-spondin recombinant protein. The culture additive is prepared from a basic fibroblast growth factor, a keratinocyte growth factor, a fibroblast growth factor 10, insulin, a p38MAPK signal channel inhibitor, an insulin-like growth factor 1, B27, nicotinamide, N-acetylcysteine, hydrocortisone, a ROCK kinase inhibitor, retinoic acid, interleukin 6, prostaglandin E2, a eriocin and androgen. According to the special culture medium for the prostatic cancer organoid, the culture success rate is increased while the cost is reduced.

The invention relates to the field of medical beauty industry, and particularly discloses intelligent response type hydroxyapatite medical beauty gel as well as a preparation method and application thereof. The intelligent response type hydroxyapatite medical beauty gel is prepared from the following raw material components: 90 to 95 parts of hydroxyapatite, 35 to 40 parts of regenerated silk fibroin composite magnetic microspheres, 50 to 55 parts of hyaluronic acid, 20 to 25 parts of recombinant III type humanized collagen and 15 to 20 parts of basic fibroblast growth factor sustained release microspheres. The preparation method comprises the following steps: uniformly dispersing all the components in hyaluronic acid, and stirring to obtain the medical beauty gel. The intelligent response type hydroxyapatite medical beauty gel belongs to an important gel material in orthopedic repair in the medical beauty industry, can well repair a bone defect part, and has excellent osteogenesis performance, biocompatibility and biological safety in vivo; and the product has the great advantages of high safety and good beautifying effect in medical beautifying bone shaping and bone repair.

The application discloses a temperature-sensitive hydrogel with a diabetes treatment effect, a kit, a use method and application thereof, and belongs to the technical field of diabetes treatment drugs. The temperature-sensitive hydrogel is formed by mixing a human umbilical vein endothelial cell suspension, a mixed solution with a final concentration of 15-20% of P407 and a final concentration of 0.6-0.8% of sodium hyaluronate, a final concentration of 50 ng / mL of vascular endothelial growth factor, a final concentration of 10 ng / mL of basic fibroblast growth factor, a final concentration of 0.5-2% of lidocaine hydrochloride, a final concentration of 100-200 mg / mL of tumor necrosis factor alpha monoclonal antibody and a final concentration of 2-5% of islet cell-alginic acid gel fiber segments with a length of less than 1 mm. The temperature-sensitive hydrogel is safe, non-toxic, low in immunogenicity, low in cost and good in treatment effect. The reagent is combined with sterile consumables to form a kit, and the kit is convenient to use and can be better applied to the treatment of diabetes.

The invention belongs to the technical field of biology, and discloses a serum-free culture medium and application thereof in obtaining nerve cells through embryo fibroblast transdifferentiation. The serum-free culture medium consists of a basic culture medium, a protein additive and cell culture auxiliary components, the protein additive consists of transferrin, a leukemia inhibition factor and a basic fibroblast growth factor; the final concentration of the transferrin is 5 ng / mL-30 ng / mL, the final concentration of the leukemia inhibition factor is 50 ng / mL-150 ng / mL, and the final concentration of the basic fibroblast growth factor is 10 ng / mL-25 ng / mL. The serum-free culture medium can promote the conversion speed of transdifferentiation of fibroblasts into nerve cells, can significantly improve the transdifferentiation efficiency, and can improve the cell survival rate of transdifferentiation of mouse embryo fibroblasts into nerve cells.

The present invention relates to a method for producing neuronal cells from dedifferentiated adipocytes derived from a mammal, the method comprising a step for culturing dedifferentiated adipocytes derived from a mammal using a medium that contains a basic fibroblast growth factor (bFGF), retinoic acid, and a neuronal differentiation inducer, but does not substantially contain an epigenetic inhibitor.

The invention relates to the field of bone tissue engineering and regenerative medicine, in particular to non-denatured bone protein calcium superfine powder with bone tissue oriented growth and rapid repair effects and a preparation method and application of the non-denatured bone protein calcium superfine powder, and the non-denatured bone protein calcium superfine powder comprises the following components in percentage by weight: 25%-45% of non-denatured type I collagen, 0.005%-0.05% of bone morphogenetic protein-2, 0.001%-0.02% of transforming growth factor-beta1, 0.01%-0.02% of calcium sulfate, 0.01%-0.02% of calcium sulfate, 0.01%-0.02% of calcium The bone tissue repairing agent is prepared from, by weight, 0.001%-0.02% of basic fibroblast growth factors, 20%-40% of ultramicro hydroxyapatite nanoparticles, 5%-15% of chitosan oligosaccharide, 3%-10% of mannitol calcium complex, 2%-8% of sodium hyaluronate, 0.01%-0.1% of vitamin D3, 0.01%-0.1% of vitamin K2, 5%-15% of chondroitin sulfate, 1%-4% of casein phosphopeptides and the balance auxiliary materials, and directional growth and rapid repairing of bone tissue are promoted.

The invention discloses a culture medium for in-vitro adherent culture of primary tumor cells and application, and relates to the technical field of tumor cell culture. Comprising a basic culture medium, fetal calf serum FBS with the concentration of 5 ng / mL-15 ng / mL, an epidermal growth factor EGF with the concentration of 1 ng / mL-10 ng / mL, a basic fibroblast growth factor bFGF with the concentration of 0.5 ng / mL-5 ng / mL, an insulin-transferrin-selenium ITS supplement with the final volume concentration of 0.1%-1%, L-glutamine with the final volume concentration of 0.5 mM-2 mM, ascorbic acid with the final volume concentration of 0.1%-0.5% and non-essential amino acid with the final volume concentration of 1%-5%. The kit comprises 10 [mu] g / mL-50 [mu] g / mL of heparin and 1 [mu] g / mL-5 [mu] g / mL of an Rho kinase inhibitor. The culture medium overcomes the defects that in the prior art, when primary tumor cells are subjected to adherent culture, apoptosis or dedifferentiation is prone to occurring, in-vivo tumor characteristics are difficult to simulate, the tumor growth speed is low, the proliferation effect is poor, and the adherent rate is low.

The invention relates to the technical field of regenerative medicine application, in particular to a serum-free induction culture medium with definite components for promoting adipose tissue-derived cells to be differentiated into dermal papilla cells, an induction method and application. The invention relates to a method for promoting adipose tissue-derived cells to differentiate into dermal papilla cells, which is characterized in that the adipose tissue-derived cells are induced and cultured by using a serum-free induction culture medium, so that the adipose tissue-derived cells are differentiated into the dermal papilla cells. The formula of the serum-free induction culture medium comprises hepatocyte growth factors, hydrocortisone, bone morphogenetic protein 2, BIO and basic fibroblast growth factors. Based on the differentiation potential of adipose tissue-derived mesenchymal cells and the function maintenance mechanism of dermal papilla cells, a serum-free induction system with definite components is constructed, and directional differentiation is realized. According to the technical scheme, the technical problem that a method for inducing the adipose-derived mesenchymal cells to be directionally differentiated into the dermal papilla cells with the effective hair follicle regulation function is lacked in the prior art can be solved, and the method has ideal application and popularization potential.

The invention discloses hydrogel capable of releasing growth factors after heat absorption and contraction and a preparation method of the hydrogel, and belongs to the field of biomedical materials. The hydrogel is of a three-layer composite structure, wherein the first layer is a sodium alginate-chitosan polyelectrolyte semi-interpenetrating network layer and serves as a compact protective layer; the second layer is a bacterial cellulose-sodium alginate high-toughness layer and is used as a bearing layer and a shrinkage driving layer; and the third layer is a basic fibroblast growth factor (bFGF)-loaded poly (butylene adipate / terephthalate) (PBAT) electrostatic spinning film layer and is used as a medicine storage cavern. According to the invention, the characteristic that the bacterial cellulose / sodium alginate layer can generate reversible heat absorption volume shrinkage at a specific temperature is used as a physical driving force to extrude and promote the bFGF in the third layer of PBAT fiber membrane to directionally release outwards.

The invention relates to the technical field of protein purification, and provides a method for eukaryotic purification of alpha-syn A53T protein through HEK293 cells. The method comprises the following steps: constructing a recombinant expression plasmid containing an SNCA-A53T mutation target fragment, inserting an affinity tag, transferring into escherichia coli, and performing amplification expression to obtain an endotoxin-free superhelix plasmid for transfection; inoculating HEK293 cells, and adding L-glutamine into the culture medium; the preparation method comprises the following steps: adding endotoxin-free superhelix plasmids and polyethyleneimine into HEK293 cells in sequence, uniformly mixing, standing, adding into the HEK293 cells, and supplementing feed Feed-1, L-glutamine, glucose, epidermal growth factors (EGF) and basic fibroblast growth factors (bFGF); agarose magnetic beads are specifically combined with an affinity tag, and then the magnetic beads are washed and eluted to obtain the purified alpha-syn A53T protein. A supplementary material Feed-1, an epidermal growth factor (EGF) and a basic fibroblast growth factor (bFGF) are introduced in an induced expression stage, so that the expression quantity and the purity of the alpha-syn A53T protein are effectively improved, and the structural stability and the functional integrity of the alpha-syn A53T protein are enhanced.

The invention relates to the technical field of biological pharmacy, and discloses a mesenchymal stem cell exosome enhancer and a preparation method thereof, the enhancer is composed of purified mesenchymal stem cell exosome, a functional lipid complex, cytokine sustained release microspheres, a targeting modifier, a stabilizer and a penetration enhancer according to specific parts by weight. The preparation method comprises the following steps: obtaining a high-activity exosome by combining ultracentrifugation with size exclusion chromatography purification; preparing a functional lipid complex composed of cholesterol, sphingomyelin and phosphatidylserine to promote membrane fusion; preparing a sodium alginate-chitosan sustained release microsphere loaded with a basic fibroblast growth factor and a transforming growth factor-beta1; synthesizing an RGD peptide modified hyaluronic acid targeting modifier; and finally, mixing the components, filtering and sub-packaging. The quality fluctuation risk of subsequent preparation preparation is reduced, and it is guaranteed that the final reinforcing agent product has a highly uniform structure.

The invention relates to the technical field of biological medicines, and provides a high VEGF protein / miR-210 extracellular vesicle induced by a serum-free combined culture medium and application of the high VEGF protein / miR-210 extracellular vesicle. According to the invention, high VEGF protein / miR-210 extracellular vesicles are obtained based on induction of a serum-free culture medium; the serum-free culture medium comprises a basic culture medium component combination: sugar-free RPMI1640 and MCDB131 in a volume ratio of 4: 1; the metabolic regulation additive is prepared by synergistically adding sodium pyruvate, cysteine and a proline hydroxylase inhibitor and taking alanine glutamine as an energy substitute; the growth factor is a combination of polyvinyl alcohol, 4-hydroxyethylpiperazine ethanesulfonic acid, ITS-X, epidermal growth factors and basic fibroblast growth factors, wherein the ITS-X, the epidermal growth factors and the basic fibroblast growth factors are added before use. CD63 and CD81 are specifically expressed on the surface of the prepared high VEGF protein / miR-210 extracellular vesicle, the high VEGF protein / miR-210 extracellular vesicle is rich in VEGF protein and miR-210, and the high VEGF protein / miR-210 extracellular vesicle is applied to targeted therapy of allergic rhinitis by inhibiting Th2 type immunoreaction.

The invention discloses a skin lesion repairing ointment and a preparation method thereof, and belongs to the technical field of medicines, and the skin lesion repairing ointment is prepared from the following raw materials: periplaneta americana, purslane, golden cypress, scutellaria baicalensis and radix sophorae flavescentis. Tests show that the skin lesion repairing ointment has the same curative effect as the compound dexamethasone acetate cream and the recombinant bovine basic fibroblast growth factor gel on skin lesion treatment, and the curative effect is more lasting. However, the specific action mechanism is still unclear, and further research is needed. In the aspect of safety, the skin lesion repairing ointment group and the compound dexamethasone acetate cream and recombinant bovine basic fibroblast growth factor gel group do not have adverse reaction, so that the external ointment and the compound dexamethasone acetate cream and recombinant bovine basic fibroblast growth factor gel group are relatively safe.

The invention relates to the technical field of organoid culture, and discloses an induction culture medium for culturing a pig lung organoid. Advanced DMEM / F12 is used as a basic culture solution of the culture medium; the invention relates to a basic fibroblast growth factor composition, which is prepared from the following added components with the final concentration: 1500ng / mL of R-Spondinin, 25ng / mL of basic fibroblast growth factor 7 (FGF7), 10100ng / mL of basic fibroblast growth factor, 100ng / mL of Noggin protein, 50ng / mL of epidermal growth factor, 50ng / mL of Wnt3a protein, 500nM of TGF-beta pathway inhibitor, 5mM of ROCK inhibitor, 500nM of p38MAPK inhibitor, 1X of B27 supplement, 1.25 mM of N-acetyl-L-cysteine, 10mM of nicotinamide, 1X of glutamine supplement GlutaMAX1X, 1X of HEPES buffer solution and 1X of broad-spectrum antibiotic (Primocin). According to the method disclosed by the invention, the lung organ with the complex multi-cell lineage is efficiently and stably constructed from the pig lung adult tissue by a one-step method. The obtained organoid is high in biomimetic property and good in stability, provides a tool platform for pig lung development research, disease model construction, drug toxicology testing and regenerative medicine research, and has great scientific research value and wide application prospects.

The present application relates to the technical field of regenerative medicine application, and particularly relates to a serum-free induction medium with clear components for promoting differentiation of adipose-derived mesenchymal cells into dermal papilla cells, and an induction method and application. A method for promoting differentiation of adipose-derived mesenchymal cells into dermal papilla cells, which is to use a serum-free induction medium to induce culture of adipose-derived mesenchymal cells, so that the adipose-derived mesenchymal cells are differentiated into dermal papilla cells. The formula of the serum-free induction medium comprises hepatocyte growth factor, hydrocortisone, bone morphogenetic protein 2, BIO, and basic fibroblast growth factor. The present application is based on the differentiation potential of adipose-derived mesenchymal cells and the mechanism of maintaining the function of dermal papilla cells, and constructs a serum-free induction system with clear components to realize directional differentiation. The technical scheme can solve the technical problem that there is no method for inducing directional differentiation of adipose-derived mesenchymal cells into dermal papilla cells with effective hair follicle regulation function in the prior art, and has ideal application and popularization potential.

The application discloses a GOFD hydrogel which can be used for treating radioactive skin injury and preparation and application thereof. The GOFD hydrogel is obtained by self-assembly of polydopamine modified graphene oxide, basic fibroblast growth factor FGF2, single-stranded DNA Y1, single-stranded DNA Y2, single-stranded DNA Y3, single-stranded DNA L4 and single-stranded DNA L5. The GOFD hydrogel not only can play a role of mechanical support and filling a wound, but also has obvious cell migration promoting activity and antioxidant activity, can effectively promote the formation of blood vessels in a damaged part and healing of the damaged part, and has a wide market prospect in preparation of a radiation protection agent and a medicine for treating radioactive skin injury.

The invention discloses a vector, a construction method thereof and application of the vector to FGF (fibroblast growth factor) obtained by expression based on a nicotiana benthamiana chassis, and belongs to the field of basic fibroblast growth factor production. The technical scheme of the invention is as follows: the biomarker comprises a carrier pJL-TRBOGZ082 or a carrier pJL-TRBGZ125; the vector pJL-TRBOGZ082 comprises a 6Xhis-FGF (Fibroblast Growth Factor) sequence as shown in SEQ ID No.1 (Sequence Identifier Number 1); the vector pJL-TRBGZ125 contains a GST (Glutathione S Transferase)-FGF (Fibroblast Growth Factor)-6 Xhis sequence as shown in SEQ ID No. 2. The method is applied to the production of the basic fibroblast growth factor, and solves the technical problems that the related research on the production of the bFGF by utilizing a tobacco transient expression technology at present is not sufficient, and particularly, the key links such as expression vector optimization, permeation infection condition control and protein purification process are still lack of system optimization. The invention provides an efficient and low-cost FGF (Fibroblast Growth Factor) production vector based on a tobacco transient expression system, a construction method of the vector and an application of the vector in obtaining the FGF based on the expression of a nicotiana benthamiana chassis.

The invention belongs to the field of medicine application, and particularly relates to application of polygonum multiflorum and an extract thereof in preparation of a medicine for repairing diabetic wounds. Cell experiments show that the polygonum multiflorum ethanol extract has remarkable in-vitro antioxidant activity and good cell safety, and can effectively enhance proliferation, migration, apoptosis resistance and oxidative stress resistance of human umbilical vein endothelial cells in a high-glucose environment by activating a P62-Keap1-Nrf2 signal channel. Animal experiments further prove that the extracting solution can remarkably accelerate wound healing of diabetic mice, relieve local inflammation infiltration, increase the collagen content, promote transformation of the diabetic mice to mature collagen and reduce the oxidative stress level of tissues at the same time. The treatment effect of the radix polygoni multiflori is equivalent to that of a clinical common drug basic fibroblast growth factor, and the radix polygoni multiflori has a wide application prospect in the aspect of wound repair of diabetes mellitus.

The invention relates to the technical field of information, and particularly provides an automatic sorting method for germline stem cells of plectropomus leopardus, which comprises the following steps: selecting healthy plectropomus leopardus as a raw material, anesthetizing with eugenol, taking gonads, cleaning the gonads with a 1 * PBS buffer solution containing antibiotics and an antifungal agent under an aseptic condition, and drying to obtain germline stem cells of plectropomus leopardus; removing surface blood vessels and coating membranes, and cutting into tissue blocks; the method comprises the following steps: re-suspending gonad cells by using a 1 * PBS buffer solution, adding a predetermined volume of suspension into the 1 * PBS buffer solution mixed with trehalose lipid and glycine betaine in a predetermined ratio, incubating, centrifuging, discarding supernatant, and pre-treating the cells to obtain pre-treated cells; putting the separated germline stem cells into a basal culture medium, adding serum, mercaptoethanol, a GlutaMAX additive, a basic fibroblast growth factor, a leukemia inhibition factor and a glial cell-derived neurotrophic factor, and culturing.

The invention relates to a method for preparing neural stem cells with high multiplication capacity, and belongs to the technical field of biology. The method comprises the following steps: separating primary neural stem cells from mammal embryo brain tissues, taking DMEM / F12 as a basic culture medium, adding B27, N2, glutamine and double antibodies, and then adding epidermal growth factors, basic fibroblast growth factors, insulin-like growth factor-1, Y-27632 and heparin to form an optimized proliferation culture medium. The method comprises the following steps: inoculating cells into a culture dish coated with polylysine and laminin, culturing under proper conditions, and digesting and subculturing after neurospheres reach a certain diameter; the method can improve the proliferation efficiency of neural stem cells and maintain stemness and differentiation potential, adopts a serum-free system, is simple and convenient to operate, and is suitable for large-scale amplification and research application.

The invention discloses a fusion protein containing a fibroblast growth factor and fibronectin and application of the fusion protein. The fusion protein comprises a fibronectin truncated fragment (such as FNIIIC or FNIIICFC) and a basic fibroblast growth factor (bFGF). The invention also provides a polynucleotide for coding the fusion protein, a recombinant expression vector and a host cell containing the polynucleotide, and a method for purifying the fusion protein through fermentation culture and affinity chromatography. Experiments show that compared with a single component or FN-full, the fusion protein, especially FNIIICFC-b, disclosed by the invention can remarkably promote proliferation and migration of mesenchymal stem cells (MSC) and up-regulate expression of beneficial factors such as HGF (Hepatocyte Growth Factor) and VEGF (Vascular Endothelial Growth Factor). The fusion protein, the pharmaceutical composition containing the fusion protein and the cell culture coating material containing the fusion protein have wide application prospects in the fields of tissue engineering, regenerative medicine and the like.

The invention provides a special culture medium for lung cancer organoid and a culture method thereof, and belongs to the technical field of biotechnology. The invention relates to a special culture medium for lung cancer organoid, which consists of a basic culture medium and a culture additive, and the basic culture medium is an Advanced DMEM / F12 culture medium, the culture additives comprise an epidermal growth factor, a basic fibroblast growth factor, a keratinocyte growth factor, a fibroblast growth factor 10, insulin, SB202190, an insulin-like growth factor 1, B27, nicotinamide, N-acetylcysteine, hydrocortisone, Y-27632, retinoic acid and interleukin 6. According to the special culture medium for the lung cancer organoids, the culture success rate of the lung cancer organoids is increased while the culture cost is reduced.

This invention discloses a recombinant human (or bovine) basic fibroblast growth factor gel with wound-healing and antibacterial functions, and its preparation method. Recombinant human (or bovine) basic fibroblast growth factor gel is a genetically engineered topical drug used clinically to promote healing of burn wounds, chronic wounds, and fresh wounds, with significant efficacy. However, its drawbacks include limited antibacterial properties and inability to be used simultaneously with chemical disinfectants such as iodine and ethanol, which, while promoting wound healing, are not conducive to controlling wound infection. Research has found that protamine sulfate or polylysine, with high safety and good antibacterial properties, can exert good antibacterial and anti-infection functions without negatively affecting the bioactivity and stability of recombinant human (or bovine) basic fibroblast growth factor. This represents an advanced method for preparing recombinant human (or bovine) basic fibroblast growth factor gel with wound-healing and antibacterial functions, enabling this type of drug to better exert its clinical effects and expand its application scope.

Provided are novel serum-free culture media which comprise basic fibroblast growth factor (bFGF), transforming growth factor beta-3 and ascorbic acid at a concentration of at least about 50 microgram / ml; ascorbic acid at a concentration range of about 400-600 microgram / ml, bFGF at a concentration range of about 50-200 ng / ml, xeno-free serum replacement and a lipid mixture; the IL6RIL6 chimera at a concentration range of about 50-200 picogram per milliliter (pg / ml); or leukemia inhibitory factor (LIF) at a concentration of at least 2000 units / ml; cell cultures comprising same with pluripotent stem cells such as human embryonic stem cells and induced pluripotent stem (iPS) cells, and methods of using same for expanding pluripotent stem cells in an undifferentiated state using two-dimensional or three-dimensional culture systems; and methods of expanding iPS cells in a suspension culture devoid of substrate adherence and cell encapsulation.

The invention relates to the field of biological tissue engineering, and discloses a shape memory polymer fiber membrane and a preparation method thereof, a shape memory polymer scaffold and a preparation method and application thereof. The polymer fiber membrane is composed of core-shell structure fibers, a fiber shell layer is selected from any one or more of thermoplastic polyurethane, a hydrogenated styrene-butadiene block copolymer, an ethylene-vinyl acetate copolymer and a polyolefin elastomer and serves as a shape memory stationary phase, a fiber core layer is a polymer with the glass transition temperature of 25-37 DEG C, and the shape memory stationary phase is a shape memory stationary phase. As a shape memory reversible phase. The shape memory polymer fiber membrane is prepared through coaxial electrostatic cospinning, and the shape memory polymer scaffold is formed by curling and adhering the fiber membrane and loads basic fibroblast growth factors. The stent can be implanted in a minimally invasive mode, body temperature triggers shape recovery, and the stent is used for urethral defect treatment.